Email updates

Keep up to date with the latest news and content from BMC Nephrology and BioMed Central.

Open Access Research article

Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis

Ron Wald12*, Andrew T Yan23, Jeffrey Perl12, Depeng Jiang45, M Sandra Donnelly12, Howard Leong-Poi23, Philip A McFarlane12, Jordan J Weinstein12 and Marc B Goldstein12

  • * Corresponding author: Ron Wald

  • † Equal contributors

Author Affiliations

1 Division of Nephrology, St. Michael's Hospital and the Univerity of Toronto, Toronto, Ontario, Canada

2 Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada

3 Division of Cardiology, St. Michael's Hospital and the Univerity of Toronto, Toronto, Ontario, Canada

4 Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada

5 Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada

For all author emails, please log on.

BMC Nephrology 2012, 13:3  doi:10.1186/1471-2369-13-3

Published: 19 January 2012



Increased left ventricular mass (LVM) is associated with adverse outcomes in patients receiving chronic hemodialysis. Among patients receiving conventional hemodialysis (CHD, 3×/week, 4 hrs/session), we evaluated whether dialysis intensification with in-centre nocturnal hemodialysis (INHD, 3×/week, 7-8 hrs/session in the dialysis unit) was associated with regression of LVM.


We conducted a retrospective cohort study of CHD recipients who converted to INHD and received INHD for at least 6 months. LVM on the first echocardiogram performed at least 6 months post-conversion was compared to LVM pre-conversion. In a secondary analysis, we examined echocardiograms performed at least 12 months after starting INHD. The effect of conversion to INHD on LVM over time was also evaluated using a longitudinal analysis that incorporated all LVM data on patients with 2 or more echocardiograms.


Thirty-seven patients were eligible for the primary analysis. Mean age at conversion was 49 ± 12 yrs and 30% were women. Mean pre-conversion LVM was 219 ± 66 g and following conversion, LVM declined by 32 ± 58 g (p = 0.002). Among patients whose follow-up echocardiogram occurred at least 12 months following conversion, LVM declined by 40 ± 56 g (p = 0.0004). The rate of change of LVM decreased significantly from 0.4 g/yr before conversion, to -11.7 g/yr following conversion to INHD (p < 0.0001).


Conversion to INHD is associated with a significant regression in LVM, which may portend a more favourable cardiovascular outcome. Our preliminary findings support the need for randomized controlled trials to definitively evaluate the cardiovascular effects of INHD.

end-stage renal disease; in-centre nocturnal hemodialysis; left ventricular mass